CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Galderma Laboratories, L.P. v. Perrigo UK FINCO L.P.

1:16-cv-00732

Overview

Case Number 1:16-cv-00732
Filing Date 2016-08-19
Status Terminated
Termination Date 2016-12-06
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Perrigo UK FINCO L.P. Operating Company

Represented By

7 Attorneys Listed

William A. Rakoczy

Email: wrakoczy@rmmslegal.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Lauren M. Lesko

Email: llesko@rmmslegal.com

Gregory A. Duff

Email: gduff@rmmslegal.com

Christine J. Siwik

Email: csiwik@rmmslegal.com

Alice L. Riechers

Email: ariechers@rmmslegal.com

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Galderma Laboratories, L.P. NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Vanessa Y. Yen

Email: vyen@kslaw.com

Evan D. Diamond

Email: ediamond@kslaw.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Perrigo Co. Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Counter Defendant

Nestle Skin Health S.A. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): 🇨🇦 Canada CN 🇪🇺 Europe 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

6 Patents

There are 6 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7439241
Compounds, formulations, and methods for treating or preventing rosacea
Filed: 2004-05-25
Issued: 2008-10-21
Expired (Term Ended) +457d PTA
Expires: 2025-08-25
US8410102
Methods and compositions for treating or preventing erythema
Filed: 2011-03-25
Issued: 2013-04-02
Expired (Term Ended)
Expires: 2024-10-23
US8426410
Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
Filed: 2009-08-21
Issued: 2013-04-23
Expired (Term Ended)
Expires: 2024-09-10
US8859551
Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
Filed: 2013-02-25
Issued: 2014-10-14
Expired (Term Ended)
Expires: 2025-01-10
US8513247
Methods and compositions for safe and effective treatment of erythema
Filed: 2011-03-25
Issued: 2013-08-20
Active (4.3 yrs remaining)
Expires: 2031-03-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+457 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(32 total)
Pleading / Complaint

COMPLAINT filed against Perrigo Co., Perrigo UK FINCO L.P. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1982903.) - filed by Nestle Skin Health S.A., Galderma Laboratories, L.P.. (Attachments: # 1 Exhibit A-F, # 2 Civil Cover Sheet)(sar) (Entered: 08/22/2016)

Entry #1 • 2016-08-19
1
Pleading / Complaint

COMPLAINT filed against Perrigo Co., Perrigo UK FINCO L.P. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1982903.) - filed by Nestle Skin Health S.A., Galderma Laboratories, L.P.. (Attachments: # 1 Exhibit A-F, # 2 Civil Cover Sheet)(sar) (Entered: 08/22/2016)

Entry #1 • 2016-08-19
2
Pleading / Complaint

COMPLAINT filed against Perrigo Co., Perrigo UK FINCO L.P. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1982903.) - filed by Nestle Skin Health S.A., Galderma Laboratories, L.P.. (Attachments: # 1 Exhibit A-F, # 2 Civil Cover Sheet)(sar) (Entered: 08/22/2016)

Entry #1 • 2016-08-19
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 08/22/2016)

Entry #2 • 2016-08-19
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 7, 2016. Date of Expiration of Patent: 7,439,241 - August 25, 2025 10,102 - May 24, 2025 8,426,410 - May 24, 2025 8,859,551 - May 25, 2024 8,513,247 - March 25, 2031 8,513,249 - March 25, 2031.Thirty Month Stay Deadline: 1/7/2019. (sar) (Entered: 08/22/2016)

Entry #3 • 2016-08-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc